Literature DB >> 11015591

Inactivation of one copy of the mouse neurotrophin-3 gene induces cardiac sympathetic deficits.

G M Story1, S E Dicarlo, D W Rodenbaugh, D E Dluzen, J Kucera, M B Maron, J M Walro.   

Abstract

Whether two copies of the neurotrophin-3 (NT3) gene are necessary for proper development of cardiac sympathetic innervation was investigated in mice carrying a targeted inactivation of the NT3 gene. Heterozygous (+/-) and null (-/-) mutant mice had fewer stellate ganglion neurons than did wild-type (+/+) mice at postnatal day 0 (P0 or birth), and this deficit was maintained between adult (P60) +/- and +/+ mice. The sympathetic innervation of the heart matured postnatally in +/+ and +/- mice. Tyrosine hydroxylase (TH)-positive axons were restricted largely to the epicardium at P0, were concentrated around large blood vessels in the myocardium at P21, and were present among cardiac myocytes at P60. Cardiac norepinephrine (NE) concentrations paralleled the growth of the sympathetic axons into the heart. NE concentrations were equivalent among +/+, +/-, and -/- mice at birth, but differences between +/- and +/+ mice increased with age. Adult +/- mice also exhibited lower resting heart rates and sympathetic tonus than +/+ mice. Thus deletion of one copy of the NT3 gene translates into anatomical, biochemical, and functional deficits in cardiac sympathetic innervation of postnatal mice, thereby indicating a gene-dosage effect for the NT3 gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015591     DOI: 10.1152/physiolgenomics.2000.2.3.129

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  1 in total

1.  Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression.

Authors:  Masaki Ieda; Keiichi Fukuda; Yasuyo Hisaka; Kensuke Kimura; Haruko Kawaguchi; Jun Fujita; Kouji Shimoda; Eiko Takeshita; Hideyuki Okano; Yukiko Kurihara; Hiroki Kurihara; Junji Ishida; Akiyoshi Fukamizu; Howard J Federoff; Satoshi Ogawa
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.